Silence Therapeutics reported $131.44M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AstraZeneca USD 114.07B 382M Dec/2025
Autolus Therapeutics Ltd USD 589.07M 72.88M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Silence Therapeutics USD 131.44M 15.35M Dec/2025